305 related articles for article (PubMed ID: 19007872)
1. Crystal structure, crystal morphology, and surface properties of an investigational drug.
Kiang YH; Yang CY; Staples RJ; Jona J
Int J Pharm; 2009 Feb; 368(1-2):76-82. PubMed ID: 19007872
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure and surface properties of an investigational drug--a case study.
Kiang YH; Shi HG; Mathre DJ; Xu W; Zhang D; Panmai S
Int J Pharm; 2004 Aug; 280(1-2):17-26. PubMed ID: 15265543
[TBL] [Abstract][Full Text] [Related]
3. The effect of crystal morphology and mill type on milling induced crystal disorder.
Chikhalia V; Forbes RT; Storey RA; Ticehurst M
Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
[TBL] [Abstract][Full Text] [Related]
4. Crystallization of carbamazepine pseudopolymorphs from nonionic microemulsions.
Kogan A; Popov I; Uvarov V; Cohen S; Aserin A; Garti N
Langmuir; 2008 Feb; 24(3):722-33. PubMed ID: 18163657
[TBL] [Abstract][Full Text] [Related]
5. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
[TBL] [Abstract][Full Text] [Related]
6. Crystal morphologies and polymorphs in tolbutamide microcrystalline powder.
Li Destri G; Marrazzo A; Rescifina A; Punzo F
J Pharm Sci; 2013 Jan; 102(1):73-83. PubMed ID: 23042550
[TBL] [Abstract][Full Text] [Related]
7. Molecular recognition and crystal energy landscapes: an X-ray and computational study of caffeine and other methylxanthines.
Carlucci L; Gavezzotti A
Chemistry; 2004 Dec; 11(1):271-9. PubMed ID: 15551321
[TBL] [Abstract][Full Text] [Related]
8. Dehydration behavior and structural characterization of the GW275919X monohydrate.
Zhu HJ
Int J Pharm; 2006 Jun; 315(1-2):18-23. PubMed ID: 16564656
[TBL] [Abstract][Full Text] [Related]
9. Characterization of complicated new polymorphs of chlorothalonil by X-ray diffraction and computer crystal structure prediction.
Tremayne M; Grice L; Pyatt JC; Seaton CC; Kariuki BM; Tsui HH; Price SL; Cherryman JC
J Am Chem Soc; 2004 Jun; 126(22):7071-81. PubMed ID: 15174878
[TBL] [Abstract][Full Text] [Related]
10. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
11. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
Cooper VB; Pearce GE; Petts CR
J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
[TBL] [Abstract][Full Text] [Related]
12. Imaging of crystal morphology and molecular simulations of surface energies in pentacene thin films.
Drummy LF; Miska PK; Alberts D; Lee N; Martin DC
J Phys Chem B; 2006 Mar; 110(12):6066-71. PubMed ID: 16553418
[TBL] [Abstract][Full Text] [Related]
13. Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour.
Cabri W; Ghetti P; Alpegiani M; Pozzi G; Justo-Erbez A; Pérez-Martínez JI; Villalón-Rubio R; Monedero-Perales MC; Muñoz-Ruiz A
Eur J Pharm Biopharm; 2006 Oct; 64(2):212-21. PubMed ID: 16846727
[TBL] [Abstract][Full Text] [Related]
14. Molecular structure of a D-homoandrostanyl steroid derivative: single crystal and powder diffraction analyses.
Martinetto P; Terech P; Grand A; Ramasseul R; Dooryhée E; Anne M
J Phys Chem B; 2006 Aug; 110(31):15127-33. PubMed ID: 16884225
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of chlorobenzylidine.
Li ZH; Ni KY; Zhou GX; Zhang C; Huang WL; Peng SX
Yao Xue Xue Bao; 2004 Jul; 39(7):546-50. PubMed ID: 15493848
[TBL] [Abstract][Full Text] [Related]
16. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M
J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244
[TBL] [Abstract][Full Text] [Related]
17. Compaction of crystallographic forms of pharmaceutical granular lactoses. II. Compacts mechanical properties.
Busignies V; Tchoreloff P; Leclerc B; Hersen C; Keller G; Couarraze G
Eur J Pharm Biopharm; 2004 Nov; 58(3):577-86. PubMed ID: 15451532
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical properties of tamoxifen hemicitrate sesquihydrate.
Kojima T; Katoh F; Matsuda Y; Teraoka R; Kitagawa S
Int J Pharm; 2008 Mar; 352(1-2):146-51. PubMed ID: 18061380
[TBL] [Abstract][Full Text] [Related]
19. Surface composition and contact angle relationships for differently prepared solid dispersions.
Dahlberg C; Millqvist-Fureby A; Schuleit M
Eur J Pharm Biopharm; 2008 Oct; 70(2):478-85. PubMed ID: 18577450
[TBL] [Abstract][Full Text] [Related]
20. Surface topography of the p3 and p6 annexin V crystal forms determined by atomic force microscopy.
Reviakine I; Bergsma-Schutter W; Mazères-Dubut C; Govorukhina N; Brisson A
J Struct Biol; 2000 Sep; 131(3):234-9. PubMed ID: 11052896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
